Information de reference pour ce titreAccession Number: | 00003612-201301000-00022.
|
Author: | Ghanizadeh, A 1,2; Berk, M 3,4
|
Institution: | (1)Research Center for Psychiatry and Behavioral Sciences, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; (2)Department of Psychiatry, Shiraz University of Medical Sciences, School of Medicine, Shiraz, Iran; (3)School of Medicine, Deakin University, Geelong, Victoria, Australia and (4)Orygen Research Centre, Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. Correspondence: Dr A Ghanizadeh, Research Center for Psychiatry and Behavioral Sciences, Department of Psychiatry, Shiraz University of Medical Sciences, Hafez Hospital, Shiraz, Iran.
|
Title: | Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials.[Miscellaneous]
|
Source: | European Journal of Clinical Nutrition. 67(1):122-124, January 2013.
|
Abstract: | : This study systematically reviews the randomized clinical trials examining the effect of zinc on attention-deficit hyperactivity disorder (ADHD), searching the PubMed/Medline and Scholar Google databases. All randomized controlled trials that examined zinc as the intervention, and ADHD as the primary outcome were included. Only three randomized controlled trials, one which included a community sample and two that included clinical samples, met inclusion criteria. The only trial that was well controlled and randomized according to the baseline zinc level showed that using zinc, either alone or in combination with stimulants, did not improve ADHD. Considering the lack of clear evidence for the effect of zinc on ADHD and the possible effect of zinc on the nervous system, more clinical studies are needed to prove or disprove the effect of zinc as a monotherapy or adjuvant therapy.
Copyright (C) 2013 Nature Publishing Group
|
Author Keywords: | attention-deficit hyperactivity disorder; zinc; psychotropic; treatment; nutrition; children.
|
References: | 1 Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M. Nutrient intakes and the common mental disorders in women. J Affect Disord 2012; 141: 79-85.
2 Schmitt KC, Reith ME. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. PLoS One 2011; 6: e25790.
3 Meinild AK, Sitte HH, Gether U. Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J Biol Chem 2004; 279: 49671-49679.
4 Ghanizadeh A, Mohammadi MR, Moini R. Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD. J Atten Disord 2008; 12: 149-155.
5 Ghanizadeh A. Parents reported oral sensory sensitivity processing and food preference in ADHD. J Psychiatr Ment Health Nurs 2011; e-pub ahead of print 6 October 2011; doi: 10.1111/j.1365-2850.2011.01830.x.
6 Kordas K, Stoltzfus RJ, Lopez P, Rico JA, Rosado JL. Iron and zinc supplementation does not improve parent or teacher ratings of behavior in first grade Mexican children exposed to lead. J Pediatr 2005; 147: 632-639.
7 Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6: e1000100.
8 Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry 2004; 4: 9.
9 Arnold LE, Disilvestro RA, Bozzolo D, Bozzolo H, Crowl L, Fernandez S et al. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. J Child Adolesc Psychopharmacol 2011; 21: 1-19.
10 Bilici M, Yildirim F, Kandil S, Bekaroglu M, Yildirmis S, Deger O et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 181-190.
11 DiGirolamo AM, Ramirez-Zea M, Wang M, Flores-Ayala R, Martorell R, Neufeld LM et al. Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala. Am J Clin Nutr 2010; 92: 1241-1250.
12 Ghanizadeh A. Overlap of ADHD and oppositional defiant disorder DSM-IV derived criteria. Arch Iran Med 2011; 14: 179-182.
|
Language: | English.
|
Document Type: | SHORT COMMUNICATION.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0954-3007
|
NLM Journal Code: | ejc, 8804070
|
DOI Number: | https://dx.doi.org/10.1038/ejcn....- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|